Carestream Health Earns 47 U.S. Patents in 2011 for Advances in Radiology, Dental and Molecular Products
These new patents include: improvements in image processing techniques for digital radiography and mammography exams; data processing enhancements for radiology information management systems such as RIS (radiology information systems) and PACS (picture archiving and communications systems); advances in camera and sensor technology for dental imaging systems; and new sensor, dye and multi-modal imaging improvements for the companys molecular imaging products.
"These patents illustrate our commitment-and success-in developing and delivering technologically advanced capabilities and new products that will help our customers enhance results in patient care, healthcare IT and research environments," said James R. Milch, Director, Research and Innovation Laboratories at Carestream.
The companys radiology products include digital imaging capture solutions for radiology and mammographic applications; digital image output to medical film and paper; RIS+PACS and vendor-neutral archiving systems; and cloud-based RIS/PACS/archiving and image sharing services. Its dental division develops and markets film and digital imaging solutions, anesthetics and practice management software.
Carestreams molecular imaging division develops and markets optical, X-ray and nuclear imaging systems, and film for in vivo and in vitro research applications.
About Carestream Health
Carestream Health, an independent company since 2007, is a worldwide provider of dental and medical imaging systems and healthcare IT solutions; molecular imaging systems for life science research and drug discovery/development; X-ray film and digital X-ray systems for non-destructive testing; and advanced materials for the precision films and electronics markets.
For more information about the companys broad portfolio of products, solutions and services, please contact your Carestream Health representative or visit www.carestream.com.
Follow Carestream Health online:
Posted by Sean Fenske, Editor-in-Chief, MDT